This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline LLC. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Maria Cichy-Knight: Innovator in Chemical Compounds
Introduction
Maria Cichy-Knight is a notable inventor based in Collegeville, PA (US). She has made significant contributions to the field of chemical compounds, particularly in the development of inhibitors for PDK1, which have potential applications in cancer treatment.
Latest Patents
Maria holds 1 patent for her invention directed to pyrido[4,3-d]pyrimidin-5(6H)-one derivatives. This invention focuses on compounds that can inhibit PDK1 activity, which is crucial in treating disorders characterized by activated ACG kinases, including various cancers such as breast, colon, and lung cancer. The patent also encompasses pharmaceutical compositions that utilize these compounds and methods for their application in medical treatments.
Career Highlights
Maria Cichy-Knight is associated with GlaxoSmithKline LLC, where she has been able to leverage her expertise in chemical compounds to advance research and development in pharmaceuticals. Her work has the potential to impact the treatment landscape for cancer patients significantly.
Collaborations
Some of her notable coworkers include Francis Louis Atkinson and Jeffrey Michael Axten, who have collaborated with her on various projects within the company.
Conclusion
Maria Cichy-Knight's innovative work in chemical compounds exemplifies the critical role of inventors in advancing medical science. Her contributions to the field of cancer treatment highlight the importance of research and collaboration in developing effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile